{"id":"W2904992990","doi":"10.1007/s10741-018-9757-1","title":"Practical guidance on the use of sacubitril/valsartan for heart failure","year":2018,"lang":"en","type":"review","venue":"Heart Failure Reviews","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"Novartis Pharmaceuticals Corporation; Heart Failure Society of America; American Heart Association","keywords":"Sacubitril; Sacubitril, Valsartan; Valsartan; Medicine; Heart failure; Ejection fraction; Reimbursement; Intensive care medicine; Internal medicine; Health care; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002408994,0.001178035,0.007389419,0.0003024148,0.0002576856,0.0001152937,0.0002979915,0.0006312236,0.0006696102],"category_scores_gemma":[0.002779382,0.0006334778,0.003057955,0.0007984263,0.0002861407,0.0002107328,0.0001631389,0.0008405263,0.002202751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002288588,"about_ca_system_score_gemma":0.000623892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001557941,"about_ca_topic_score_gemma":0.00004854657,"domain_scores_codex":[0.9936971,0.001170122,0.002343055,0.001165715,0.0007369102,0.0008870647],"domain_scores_gemma":[0.9935668,0.002200354,0.0009560809,0.002556989,0.0003401812,0.0003796653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003630466,0.0003005266,0.000009852697,0.02531001,0.0003482928,0.000008436067,0.00001548764,3.565704e-8,0.000003792282,0.001430479,0.9336972,0.03883956],"study_design_scores_gemma":[0.0004579668,0.000882266,0.000001757164,0.04474474,0.003934626,0.0001878542,0.000009149426,0.0000038147,0.00001713502,0.00001320497,0.9492695,0.0004779465],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[9.108682e-7,0.9324096,0.0003433158,0.0504238,0.0003064859,0.01620061,0.0001080346,0.00009635332,0.0001108429],"genre_scores_gemma":[6.671605e-7,0.8632689,0.1271368,0.002693454,0.001038016,0.002479108,0.0002181924,0.0001663064,0.00299858],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1267935,"threshold_uncertainty_score":0.9996117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2446787472147415,"score_gpt":0.4246198927189778,"score_spread":0.1799411455042363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}